Shares of Chemed Corporation (NYSE:CHE – Get Free Report) have been given a consensus recommendation of “Hold” by the six research firms that are covering the company, MarketBeat Ratings reports. Five equities research analysts have rated the stock with a hold recommendation and one has assigned a buy recommendation to the company. The average 1 year target price among brokers that have updated their coverage on the stock in the last year is $480.25.
CHE has been the subject of a number of analyst reports. Zacks Research raised Chemed from a “strong sell” rating to a “hold” rating in a research note on Monday, April 27th. Royal Bank Of Canada increased their price objective on Chemed from $422.00 to $436.00 and gave the stock a “sector perform” rating in a research report on Monday, April 27th. Wall Street Zen downgraded Chemed from a “buy” rating to a “hold” rating in a report on Monday, June 8th. Bank of America upped their price target on shares of Chemed from $450.00 to $510.00 and gave the stock a “neutral” rating in a research note on Thursday. Finally, Weiss Ratings upgraded shares of Chemed from a “sell (d+)” rating to a “hold (c-)” rating in a report on Wednesday, April 29th.
Read Our Latest Research Report on CHE
Insider Transactions at Chemed
Institutional Trading of Chemed
Several large investors have recently modified their holdings of CHE. Intech Investment Management LLC acquired a new stake in Chemed in the 3rd quarter worth about $1,429,000. SG Americas Securities LLC grew its holdings in Chemed by 773.5% in the 4th quarter. SG Americas Securities LLC now owns 26,466 shares of the company’s stock valued at $11,324,000 after buying an additional 23,436 shares during the period. BNP Paribas Financial Markets increased its stake in shares of Chemed by 14.5% during the 4th quarter. BNP Paribas Financial Markets now owns 35,024 shares of the company’s stock valued at $14,985,000 after acquiring an additional 4,430 shares during the last quarter. Abacus FCF Advisors LLC purchased a new position in shares of Chemed during the 4th quarter worth about $5,935,000. Finally, TD Asset Management Inc lifted its holdings in shares of Chemed by 7.5% during the 4th quarter. TD Asset Management Inc now owns 324,546 shares of the company’s stock worth $138,860,000 after acquiring an additional 22,715 shares during the period. 95.85% of the stock is currently owned by institutional investors and hedge funds.
Chemed Stock Performance
Shares of CHE stock traded down $2.70 during mid-day trading on Friday, hitting $487.76. The stock had a trading volume of 143,289 shares, compared to its average volume of 193,784. The firm has a market cap of $6.47 billion, a PE ratio of 26.58, a PEG ratio of 1.80 and a beta of 0.52. The company’s 50-day simple moving average is $443.16 and its 200-day simple moving average is $428.70. The company has a debt-to-equity ratio of 0.11, a current ratio of 0.85 and a quick ratio of 0.83. Chemed has a fifty-two week low of $365.20 and a fifty-two week high of $493.47.
Chemed (NYSE:CHE – Get Free Report) last posted its quarterly earnings results on Thursday, April 23rd. The company reported $5.65 earnings per share (EPS) for the quarter, topping the consensus estimate of $5.30 by $0.35. Chemed had a net margin of 10.23% and a return on equity of 27.18%. The firm had revenue of $657.51 million during the quarter, compared to analysts’ expectations of $659.22 million. During the same period in the prior year, the company posted $5.63 earnings per share. The firm’s revenue for the quarter was up 1.6% on a year-over-year basis. Chemed has set its FY 2026 guidance at 24.000-24.75 EPS. Sell-side analysts anticipate that Chemed will post 22.67 earnings per share for the current year.
Chemed Announces Dividend
The business also recently announced a quarterly dividend, which was paid on Tuesday, June 16th. Shareholders of record on Thursday, May 28th were given a dividend of $0.60 per share. This represents a $2.40 annualized dividend and a yield of 0.5%. The ex-dividend date was Thursday, May 28th. Chemed’s dividend payout ratio is presently 13.08%.
About Chemed
Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.
The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.
Featured Stories
- Five stocks we like better than Chemed
- 3 Rare-Earth ETFs That Help Investors Balance Exposure and Risk
- Microsoft Bets on In-House AI to Cut OpenAI and Anthropic Costs
- Delta Air Lines Lives Up to Its Claims: Shares Can Keep Climbing
- This Dividend ETF Choice Could Shape Your Income Strategy Through 2026
Receive News & Ratings for Chemed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed and related companies with MarketBeat.com's FREE daily email newsletter.
